bipiperidyl mustard (BPM)

Subscribe to Selected New Research on bipiperidyl mustard

884 relevant articles (19 outcomes, 48 trials/studies) found for this Bio-Agent

Description: RN given refers to parent cpd; structure

Also Known As:

BPM; bipiperidyl mustard dihydrochloride; 1,1'-bis(beta-chloroethyl)-4,4'-bipiperidine

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 40

Hydrocarbons: 382

Halogenated Hydrocarbons: 28

Mustard Compounds: 3

bipiperidyl mustard: 884

Experts

1.	Duhamel, Alain: 1 article (10/2008)
2.	Faivre, Jean-Baptiste: 1 article (10/2008)
3.	Pansini, Vittorio: 1 article (10/2008)
4.	Tacelli, Nunzia: 1 article (10/2008)
5.	Remy, Jacques: 1 article (10/2008)
6.	Remy-Jardin, Martine: 1 article (10/2008)
7.	Deken, Valérie: 1 article (10/2008)
8.	Flohr, Thomas: 1 article (10/2008)

Related Diseases

1.	Bradycardia 05/30/2007 - "Exercise training induced resting bradycardia (340+/-5 vs. 316+/-8 bpm) and improvement in baroreflex tachycardic response (3.4+/-0.31 vs. 2.7+/-0.06 bpm/mmHg in SC) and chemoreflex bradycardic (145+/-12 vs. 78+/-7 bpm in SC) and pressor (49+/-5 vs. 22+/-3 mmHg in SC) responses in control rats" 07/01/2008 - "The primary study variable was the combined event rate of desaturations (SpO2 <85%) and bradycardias (heart rate <80 bpm)" 11/01/2008 - "In the post-retirement period, a total of 65 % of participants had persistent bradycardia, 18 % with bradycardia < 50 bpm" 11/01/2008 - "We performed a longitudinal follow-up study in 157 former elite athletes who had records of bradycardia < 50 bpm when they were active in high-level competition" 06/01/2008 - "Seventeen hours later, the patient presented drowsiness and a sinus bradycardia of 40 bpm" Order ALL the reference details at left...
2.	Tachycardia (Tachyarrhythmias) 02/01/1990 - "However, anaesthesia as compared to conscious studies resulted in a marked tachycardia (147 +/- 30 bpm, vs 98 +/- 19 bpm, p less than 0.0005), significantly lower right atrial pressure (5 +/- 2 mmHg vs 8 +/- 2 mmHg, p less than 0.05), and a trend towards a lower pulmonary capillary wedge pressure (6 +/- 5 mmHg vs 9 +/- 3 mmHg)" 04/19/1988 - "In the present study, in control rats, marked tachycardia (406 +/- 11 vs 320 +/- 4 bpm during the control period) was observed on the first day of electrolytic lesion of the anteroventral third ventricle (AV3V) region" 04/01/1987 - "An electrophysiological study had revealed an ectopic right-atrial tachycardia and fast AV conduction up to a rate of more than 180 bpm" 09/01/1983 - "This study examines the clinical setting, characteristics, and follow-up of 173 patients who had slow paroxysmal atrial tachycardia (SPAT) (greater than 4 beats, rate less than 150 bpm) during 24-hour Holter monitoring" 05/01/2008 - "A stepwise increase in heart rate was observed that was dependent on the number of tachycardia-associated alleles with progressive increases in mean heart rate from 51 to 66 bpm" Order ALL the reference details at left...
3.	Atrial Fibrillation 04/01/2001 - "The purpose of this study was to assess the efficacy of overdrive, single-site right atrial appendage pacing to reduce the burden of atrial fibrillation (AF) when compared with a standard lower rate limit of 60 bpm" 03/01/1997 - "In the electrophysiological study, we found dual atrioventricular nodal pathways, an atrioventricular effective refractory period of 210 ms, and an inducible atrial fibrillation with a ventricular response of 210 bpm that produced hemodynamic collapse" 06/01/2007 - "A second ECG, 16 hours post ingestion, reflected atrial fibrillation with a ventricular rate of 125 to 147 bpm" 02/21/2006 - "METHODS AND RESULTS: Twenty-two patients (aged 66+/-2 years, QRS 179+/-8 ms, LV ejection fraction 23+/-1%) underwent cardiac catheterization before device implantation to measure LV hemodynamics at baseline (rate 68+/-2 bpm; sinus rhythm n=18; atrial fibrillation n=4) and during BiV, LV, and right ventricular (RV) stimulation at 80, 100, 120, and 140 bpm" 03/01/2005 - "In the RAP group, atrial pacing was performed with a rate of 400 bpm for 10 weeks to establish atrial fibrillation model" Order ALL the reference details at left...
4.	Breast Neoplasms (Breast Cancer) 01/01/2004 - "REVIEWERS' CONCLUSIONS: While published observational studies demonstrated that BPM was effective in reducing both the incidence of, and death from, breast cancer, more rigorous prospective studies (ideally randomized trials) are needed" 01/01/2004 - "All studies reporting on incidence of breast cancer and disease-specific mortality reported reductions after BPM" 11/01/2006 - "Research indicates that there are psychological benefits to BPM, including a reduction in anxiety about developing breast cancer" 11/01/2006 - "Thus, women who are at high risk for familial breast cancer are increasingly opting for BPM as a preventative option" 01/01/2004 - "Worry over breast cancer was significantly reduced after BPM when compared both to baseline worry levels and to the groups who opted for surveillance rather than BPM" Order ALL the reference details at left...
5.	Body Weight (Weight, Body) 07/01/2003 - "After approximately 6 weeks of the high fat diet, body weight (36.3+/-0.4 vs 21.5+/-0.5 kg), mean arterial pressure (105+/-4 vs 91+/-3 mm Hg), and heart rate (97+/-4 vs 70+/-3 bpm) were significantly greater in obese than in control dogs, respectively" 06/01/2004 - "Of the 51 patients randomized (average age 61.2+/-9 years, blood pressure 148/100 mm Hg, heart rate 74 bpm, and body weight 92.8 kg), 44 completed the study" 11/01/2006 - "The LPS administration induced a significant decrease in MAP (-15.4 +/- 1.2 mmHg at second hour, -25.8 +/- 8.7 mmHg at fourth hour, and -22.3 +/- 8.6 mmHg at sixth hour) with a concomitant increase in heart rate (486.3 +/- 55.0, 531.8 +/- 53.8, and 510.0 +/- 55.3 bpm, respectively), a significant decrease in diuresis (from 1.1 +/- 0.7 to 0.4 +/- 0.3/100g body weight at fourth hour), and a transitory decrease in body temperature (from 37.0 +/- 0.5 to 35.4 +/- 0.8 degrees C at second hour)" 10/01/2006 - "RESULTS: Main results (mean+/-SD) were as follows: OI was 12.0+/-0.8; peak ground reaction force (GRF) was 1.40+/-0.10 times body weight (BW); session duration was 38.6+/-8.3 min; stepping rate was 134.6+/-4.7 beats per minute (bpm); the movements performed most often were marching, knee hop, side leg, L step, and over the top; and the number of loading cycles was 4194.1+/-1055.2" 07/30/2004 - "IPM showed an increased cardiac weight/body weight (1.18 +/- 0.03 mg/g) ratio compared to CM (0.95 +/- 0.03 mg/g, p<0.05), but similar values of resting MAP (108 +/- 4 vs. 111 +/- 2 mm Hg) and HR (606 +/- 25 vs. 629 +/- 26 bpm)" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Oxygen
2.	Metoprolol (Lopressor)
3.	Ephedrine
4.	Enoximone
5.	Fluoxetine (Prozac)
6.	milnacipran (Ixel)
7.	2-methyl-5-HT
8.	Gm(m)
9.	Propranolol (Inderal)
10.	Dichlorodiphenyldichloroethane (DDD)

Related Therapies and Procedures

1.	Mastectomy (Mammectomy)
2.	Stents
3.	Percutaneous Coronary Transluminal Angioplasty (PTCA)
4.	Angioplasty (Angioplasties)
5.	Anesthesia

Best Treatments:
Research Summary Report
on Bradycardia

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 225 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>